Search results for "innovation"

Article Innovations in Perfusion Bioprocessing
In this study, we present a method for deriving perfusion culture media by leveraging existing fed-batch media and feeds. Furthermore, we illustrate the successful transfer of the develop…

Article On-demand webinar: Balancing innovation, speed, and robustness to improve efficiency in upstream process development
Did you miss our webinar on accelerating biopharma development cycles? Watch it now, on demand! We'll cover strategies like cell line development, media development, and raw material characte…

Article Balancing innovation, speed, and robustness to improve efficiency in upstream process development.
Date: April 26, 2023 2:00pm CEST(8:00am EDT) Register today

Webcast Balancing innovation, speed, and robustness to improve efficiency in upstream process development.
Date: April 26, 2023 2:00pm CEST(8:00am EDT) Register today

Article Chromatography innovations for the diverse antibody pipeline
To support development of new therapeutic possibilities, manufacturing and process development technologies must also evolve. For antibody variants, platform purification protocols for conve…

Article Cytiva Acquires Vanrx, Innovator in Aseptic Filling
Click here to read more >> Cytiva acquires Vanrx to extend its single-use manufacturing platform with aseptic-filling solutions.

Article Current Innovations and Practices To Address Microbial Contamination in Downstream Bioprocessing
Bioburden control is an area of serious concern for anyone making mAbs or other biologicals. Manufacturers’ efforts to avoid microbial contamination are today being complemented by development…

Article Maximum Output Starts with Optimized Upstream Processing
Process flexibility and technical innovations are key strategies to accelerate the pace of process development while increasing upstream capacity, adds Dirk Lange, CEO of Selexis and president and CEO…

Article Methods Accelerate Biosimilar Analysis
Methods Accelerate Biosimilar Analysis Effective application of mass-spectrometry tools can optimize biosimilar analysis, reducing development time and cost. By Mario DiPaola, …

Article Moving Biosimilars Forward in a Hesitant Market
Another hindrance to progress is the ideology of adopting the innovation aspect and including it to justify one’s data to FDA, Bukhari adds. “Say [a company has] taken up an innovative method to produ…

Previous PageNext Page